Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514357 | 0.83 | ELANE (0.72) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL29187166 | 0.83 | ELANE (0.72) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL2459478 | 0.83 | ELANE (0.56) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL22279461 | 0.82 | KMT2A (0.56) | ELANEALDH1A1TP53KMT2AHSD17B10 | |
| Hydrochloric Acid SCHEMBL25243908 | 0.81 | ELANE (0.70) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL15064173 | 0.81 | ELANE (0.55) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL3740302 | 0.81 | ELANE (0.55) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL197674 | 0.81 | ELANE (0.55) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL30894420 | 0.81 | ELANE (0.70) | ELANEATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL3744640 | 0.81 | ELANE (0.55) | ELANEATML3MBTL1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10384247-B2 | Process for obtaining ionic amino acid esters | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2019-08-20 | — | — | US | disclosed |
| CN-103261157-B | Strigolactam derivative and the purposes as plant-growth regulator thereof | SYNGENTA PARTICIPATIONS AG (CH) | 2015-12-09 | — | — | CN | disclosed |
| CN-103261157-A | Strigolactam derivatives and their use as plant growth regulators | SYNGENTA PARTICIPATIONS AG | 2013-08-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10384247-B2 | Process for obtaining ionic amino acid esters | BCAT2, BCAT1, FASN | ELANE 1837/4885ATM 3155/4885L3MBTL1 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.